[Home] [Reports] [Startups] [ONLINE STORE] [site map]


Order Report via our online store

The report below has been updated in the 2010 report on

"Products, Technologies, Markets and Opportunities

in Diabetes Management Worldwide, 2009-2018"

Click for details


Products, Technologies, Markets and Opportunities in

 Diabetes Management Worldwide, 2005-2015

Report D500

276 pages   · 82 Exhibits   · 96 Company Profiles   · February 2006   · Report #D500

Worldwide report on products, trends, competitors and markets for diabetes management.

This report details the worldwide incidence and prevalence by country/region of Type 1 and Type 2 diabetes and details the current and projected market for diagnostic and therapeutic products in the management of diabetes, including anti-diabetic drugs, alternative insulin types, blood glucose monitoring (including continuous monitoring devices), insulin pumps, and other established and emerging products in diabetes management.  The report provides an emphasis of detail on the status of development of novel products including noninvasive monitoring, oral/inhaled/other insulin delivery. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.  Separate size, growth and competitor share data are presented for the U.S., individual western European countries (Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom), and Japan.  The report profiles active companies including detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, plus additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Products & Technologies Covered:

  • Oral hypoglycemic drugs

  • Insulin by type

  • Blood glucose monitors

  • Lancets

  • Blood sampling devices

  • HbA1c testing

  • Insulin pumps

  • Insulin syringes

  • Inhaled insulin

  • Artificial pancreas

  • Pancreatic transplant

  • Islet cell transplants

  • Stem cell

  • Antibody treatment

  • Vaccines

  • Genetic approaches

  • Novel drugs

  • Continuous glucose monitoring


Table of Contents



Some Diabetes Basics

A Large and Growing Market

A Many-Sided Market

Pharmaceuticals for Diabetes


Oral Anti-diabetic Drugs

The Pharmaceutical Diabetes Market

Insulin Administration Devices

Medical Devices for Diabetes

Total Diabetes Market

Regional Segmentation

Market Growth

The Diabetes Industry

Pharmaceutical Companies

Medical Device Companies

Section 1:        ABOUT DIABETES


1.1       What is Diabetes?


1.2       Blood Sugar Regulation

1.2.1          Insulin

1.3       Main Types of Diabetes

1.3.1          Type 1 Diabetes

1.3.2          Type 2 Diabetes

1.3.3          Gestational Diabetes

1.3.4          Obesity-Related type 2 Diabetes in Children.

1.3.5          Mature-onset Diabetes of the Young (MODY)

1.3.6          Other Diabetic States

1.4       Diagnosis

1.4.1          Glucose Tests

1.4.2          Official Criteria

1.4.3          Differential Diagnosis       Type 1 Diabetes       Type 2 Diabetes

1.5       Current Treatment

1.5.1          Type 1 Diabetes

1.5.2          Type 2 Diabetes

1.5.3          Diet

1.6       Future Treatment Approaches


1.7       Treatment Monitoring

1.7.1          Blood Sugar Control

1.7.2          The Diabetes Control and Complications Trial

1.7.3          Glycated haemoglobin (HbA1c)

1.7.4          Fructosamine

1.8       Incidence and Prevalence of Diabetes (Type 1 & Type 2)

1.8.1          Worldwide

1.8.2          USA

1.8.3          Japan

1.8.4          Europe

1.9       Diabetic Complications

1.9.1          Retinopathy

1.9.2          Neuropathy

1.9.3          Nephropathy

1.10     Metabolic Syndrome


Section 2:        Products Used in Diagnosis and Monitoring


2.1       Blood Glucose Monitoring Devices:  Suppliers and Products

2.1.1          Lancets

2.1.2          Blood Sampling Devices       Bayer Diagnostics       Becton Dickinson       Cell Robotics       LifeScan       Roche Diagnostics

2.1.3          Blood Glucose Monitors       77 Elektronica Kft       Abbott Laboratories       Acon Laboratories Inc.       Apex Biotechnology Corp.       Bayer Corporation       Becton Dickinson & Co       Belbiosens       Cygnus Inc – Animas Corp       Diagnostic Devices Inc.     Eumed Biotechnology Co. Ltd.     HMD Bio Medical     Glucoplus Inc     HemoCue AB     Home Diagnostics Inc     Hypoguard     LifeScan Inc     Medtronic MiniMed     Polymer Technology Systems Inc.     QuestStar Medical Inc     Roche     TaiDoc Technology Corporation     US Diagnostics Inc.

2.1.4          New Developments in Glucose Testing

2.2       ‘Artificial Pancreas’

2.2.1          Medtronic

2.2.2          Roche

2.2.3          Abbott

2.2.4          Novo Nordisk/LifeScan

2.3       Other Testing Approaches

2.3.1          Hemoglobin A1c       Hemoglobin A1c Meters       Hemoglobin A1c Kits

2.4       Software Programs for Diabetes Monitoring.

2.4.1          Web Software

2.4.2          Commercial Software

Section 3:        Products Used in Treatment


3.1       Insulin

3.1.1          History       Bovine and Porcine Insulin       Humanized Insulin

3.1.2          Companies Supplying Insulin       Eli Lilly       Aventis       Novo Nordisk       Some Other Suppliers

3.1.3          Insulin Delivery       Syringes

3.1.4          Insulin Syringe Manufacturers       Pens       Manufacturers of Insulin Pens       Injectors       Injector Manufacturers

3.1.5          Inhaled insulin

3.1.6          Pfizer/Sanofi-Aventis/Nektar Therapeutics       Lilly/Alkermes       Novo Nordisk/Aradigm       MannKind

3.1.7          Insulin Pumps       What is an Insulin Pump?       The Infusion Set       Candidates for Pump Therapy

3.1.8          Companies Supplying Insulin Pumps       Animas Corporation       DANA Diabecare       Medtronic MiniMed       Nipro Diabetes Systems       Roche Disetronic       Smiths Medical

3.2       Oral Hypoglycaemic Drugs

3.2.1          Sulfonylureas

3.2.2          Biguanides

3.2.3          Alpha-Glucosidase Inhibitor

3.2.4          Thiazolidinediones

3.2.5          Prandial Glucose Regulators

3.2.6          Incretin Mimetics

3.2.7          Amylin Mimetic

3.2.8          New Products Now in R&D

Section 4:        Novel Approaches to Diabetes Management


4.1       Pancreas Transplants


4.2       Islet Cell Transplants

4.2.1          Edmonton Protocol

4.2.2          Improving ICT

4.2.3          Living-Donor Islet Cell Transplant

4.3       Stem Cell Developments

4.3.1          ADA Endorsement

4.3.2          Stem Cell Research at EASD 2005       Adult Stem Cells

4.4       Antibody Treatment


4.5       Vaccines

4.5.1          Diamyd Medical

4.5.2          DeveloGen

4.6       Genetic Approaches

4.6.1          Genetic Testing

4.6.2          Small-interfering RNA (SiRNA)

4.7       Novel Drugs

4.7.1          DDP-IV Inhibitors

4.7.2          Other Drugs

4.7.3          All-in-one Treatment for Type 2 Diabetes?

4.8       Continuous Glucose Monitoring

4.8.1          Electroenzymatic Sensor

4.8.2          Optical Glucose Sensor

4.8.3          Sensor Based on Carbon Nanotubes


Section 5:        The Diabetes Market


5.1       Global Market

5.1.1          Size

5.1.2          Growth

5.1.3          Regional Segmentation

5.2       Market Analysis by Product Category

5.2.1          Monitoring Products       Major Suppliers

5.2.2          Insulins and Insulin Delivery Devices       Major Suppliers          Insulin          Syringes and Other Insulin Administration Devices          Insulin Pumps

5.2.3          Oral Antidiabetic Drugs       Major Suppliers

5.3       Trends


5.4       Main National Markets

5.4.1          Belgium

5.4.2          Denmark

5.4.3          France

5.4.4          Germany

5.4.5          Italy

5.4.6          Japan

5.4.7          Netherlands

5.4.8          Norway

5.4.9          Spain

5.4.10        Sweden

5.4.11        United Kingdom

5.4.12        USA

Section 6:        Company Profiles


6.1       Leading Companies

6.1.1          Abbott Laboratories       Overview       Diabetes Products       Pipeline       Financials

6.1.2          Bayer       Overview       Diabetes Products          Ascensia Blood Glucose Monitoring       Financials

6.1.3          Becton Dickinson       Overview       Diabetes Products          Insulin Injection Devices          Glucose monitoring products       Financials

6.1.4          Bristol-Myers Squibb       Overview          Problems with Generics       Diabetes Products       Financials

6.1.5          Eli Lilly       Overview       Diabetes Products       Financials       Pipeline

6.1.6          Glaxo SmithKline       Overview       Diabetes products       Financials       Pipeline

6.1.7          Johnson & Johnson       Overview       Diabetes Products       Financials

6.1.8          Medtronic       Overview       Diabetes Products          Paradigm 512/712 insulin pump          Paradigm 515/715 insulin pump          CGMS System Gold       Financials       Pipeline

6.1.9          Merck KgaA       Overview       Diabetes Product       Financials

6.1.10        Novartis     Overview     Diabetes Product     Financials     Pipeline

6.1.11        Novo Nordisk     Overview     Diabetes Products        Pharmaceuticals     Financials     Pipeline

6.1.12        Pfizer     Overview     Diabetes Products     Financials     Pipeline

6.1.13        Roche     Overview     Diabetes Products        Accutrend GC/GCT     Financials     Pipeline

6.1.14        Sanofi-Aventis     Overview     Diabetes Products     Financials     Pipeline

6.1.15        Takeda     Overview     Diabetes Products     Financials     Pipeline        TAK-559        TAK-654

6.2       Other Companies

6.2.1          77 Elektronica

6.2.2          Acon Laboratories

6.2.3          Activa

6.2.4          AdipoGenix

6.2.5          AgaMatrix

6.2.6          AiMedics Pty Ltd

6.2.7          Alkermes Inc.

6.2.8          Amylin

6.2.9          Animas Corp.

6.2.10        Antares Pharma

6.2.11        Apex Biotechnology Ltd

6.2.12        Aradigm

6.2.13        Arena Pharmaceuticals

6.2.14        B Braun

6.2.15        Belbiosens

6.2.16        Benitec Limited

6.2.17        Biocon

6.2.18        Bioject Medical Technologies Inc.

6.2.19        BioSafe Medical Technologies Inc

6.2.20        Biovitrum

6.2.21        Cell Robotics International, Inc

6.2.22        ChemGenex Pharmaceuticals Ltd

6.2.23        Dana Diabecare USA

6.2.24        Devgen NV

6.2.25        Dexcom Inc

6.2.26        Diabetes Technologies Inc.

6.2.27        Diagnostic Devices Inc.

6.2.28        Diosynth

6.2.29        EnGene

6.2.30        Equidyne Corporation

6.2.31        Eumed Biotechnology Co. Inc

6.2.32        FivePrime Therapeutics

6.2.33        FlexSite Diagnostics

6.2.34        Fluent Biomedical Inc

6.2.35        GlucoLight Corporation

6.2.36        Glucon Medical Ltd

6.2.37        Glucoplus Inc

6.2.38        GluMetrics LLC

6.2.39        Hemocue AB

6.2.40        Hitachi Ltd

6.2.41        HMD Biomedical

6.2.42        Home Diagnostics Inc

6.2.43        HypoGuard

6.2.44        Infratec Inc

6.2.45        InLight Solutions Inc

6.2.46        Integrity Applications Ltd

6.2.47        Kumetrix Inc

6.2.48        Laboratorios Beta

6.2.49        LifeTrac Systems Inc

6.2.50        Ligand Pharmaceuticals Inc

6.2.51        MannKind

6.2.52        Menarini

6.2.53        Metabolex

6.2.54        Metrika Inc.

6.2.55        Nektar Therapeutics

6.2.56        Nipro Diabetes Systems Inc

6.2.57        Owen Mumford

6.2.58        Palco Laboratories

6.2.59        Pelikan Technologies

6.2.60        Pindi Products

6.2.61        Polymer Technology Systems Inc

6.2.62        Provalis plc

6.2.63        QuestStar Medical Inc

6.2.64        Quotient Diagnostics Ltd

6.2.65        Rosch AG Medizintechnik

6.2.66        Sanwa Kagaku Kenkyusho Co. Ltd.

6.2.67        SenSys Medical

6.2.68        Laboratoires Servier

6.2.69        Sirna Therapeutics

6.2.70        Smiths Medical

6.2.71        Sontra Medical Corporation

6.2.72        SpectRx Inc

6.2.73        TaiDoc Technology Corporation

6.2.74        Terumo Medical Corporation

6.2.75        Theratechnologies Inc.

6.2.76        TolerRx Inc.

6.2.77        US Diagnostics Inc

6.2.78        Vaxine Pty Ltd.

6.2.79        VeraLight Inc.

6.2.80        Vivo Medical Inc.

6.2.81        Wockhardt Ltd

Appendix:  Company Addresses



List of Exhibits

Exhibit ES-1:  Total Diabetes Market, 2004

Exhibit ES-2:  Regional Segmentation of Diabetes Market


Exhibit 1.1:  Threshold Glucose Levels Indicative of Diabetes/Hyperglycemia (mmol/L)

Exhibit 1-2:  Main Brands and Types of Insulin

Exhibit 1-3:  Oral Diabetes Treatments

Exhibit 1-4:  Prevalence of Diabetes by Region (Age 20-79 Years)

Exhibit 1-5:  Differences in the Prevalence of Type 2 Diabetes Among Selected Ethnic Groups, 2003

Exhibit 1-6:  Prevalence of Diabetes in USA, 2003

Exhibit 1-7:  Incidence of Type 1 Diabetes in Western European countries (Cases per 100,000 Child Population, per Annum)

Exhibit 1-8:  Type 1 Diabetes Incidence Growth Rates in Selected European Countries

Exhibit 1-8:  Estimated Prevalence of Type 2 Diabetes in Western European Countries


Exhibit 2-1:  International Suppliers of Blood Lancets

Exhibit 2-2:  Blood Glucose Meters

Exhibit 2-3:  Research Projects in Glucose Monitoring

Exhibit 2-4:  Commercial Software Programs for Windows and Macintosh


Exhibit 3-1:  Major Brands of Insulin

Exhibit 3-2:  Manufacturers of Insulin Pens

Exhibit 3-3:  Manufacturers of Insulin Pups

Exhibit 3-4:  Sulfonylureas

Exhibit 3-5:  Oral Hypoglycemics


Exhibit 5-1:  Prevalence of Diabetes Mellitus, by Selected Country, 2003 and 2025 (Percent of Population Age 20-79)

Exhibit 5-2:  Global Diabetes Market 2004

Exhibit 5-3:  Relative Market Size of Major Regional Diabetes Markets; USA, Western Europe and Japan

Exhibit 5-4:  Glucose Monitors: Leading Companies 2004

Exhibit 5-5:  Market Shares, Insulin, Worldwide, 2004

Exhibit 5-6:  Market Shares, Insulin Syringes, Worldwide, 2004

Exhibit 5-7:  Market Shares, Insulin Pens, Worldwide, 2004

Exhibit 5-8:  Market Shares, Insulin Pumps, Worldwide, 2004

Exhibit 5-9:  Market Shares, Oral Antidiabetic Drugs, Worldwide, 2004

Exhibit 5-10:  Market for Insulin and Other Diabetes Medications, Belgium, 2003-2015

Exhibit 5-11:  Market for Glucose Meters, Belgium, 2003-2015

Exhibit 5-12:  Market for Insulin Pumps, Belgium, 2003-2015

Exhibit 5-13:  Market for Insulin and Other Diabetes Medications, Denmark, 2003-2015

Exhibit 5-14:  Market for Glucose Meters, Denmark, 2003-2015

Exhibit 5-15:  Market for Insulin and Other Diabetes Medications, France, 2003-2015

Exhibit 5-16:  Market for Glucose Meters, France, 2003-2015

Exhibit 5-17:  Market for Insulin Pumps, France, 2003-2015

Exhibit 5-18:  Market for Insulin and Other Diabetes Medications, Germany, 2003-2015

Exhibit 5-19:  Market for Glucose Meters, Germany, 2003-2015

Exhibit 5-20:  Market for Insulin Pumps, Germany, 2003-2015

Exhibit 5-21:  Market for Insulin and Other Diabetes Medications, Italy, 2003-2015

Exhibit 5-22:  Market for Glucose Meters, Italy, 2003-2015

Exhibit 5-23:  Market for Insulin Pumps, Italy, 2003-2015

Exhibit 5-24:  Market for Insulin and Other Diabetes Medications, Japan, 2003-2015

Exhibit 5-25:  Market for Glucose Meters, Japan, 2003-2015

Exhibit 5-26:  Market for Insulin Pumps, Japan, 2003-2015

Exhibit 5-27:  Market for Insulin and Other Diabetes Medications, Netherlands, 2003-2015

Exhibit 5-28:  Market for Glucose Meters, Netherlands, 2003-2015

Exhibit 5-29:  Market for Insulin Pumps, Netherlands, 2003-2015

Exhibit 5-30:  Market for Insulin and Other Diabetes Medications, Norway, 2003-2015

Exhibit 5-31:  Market for Glucose Meters, Norway, 2003-2015

Exhibit 5-32:  Market for Insulin Pumps, Norway, 2003-2015

Exhibit 5-33:  Market for Insulin and Other Diabetes Medications, Spain, 2003-2015

Exhibit 5-34:  Market for Glucose Meters, Spain, 2003-2015

Exhibit 5-35:  Market for Insulin Pumps, Spain, 2003-2015

Exhibit 5-36:  Market for Insulin and Other Diabetes Medications, Sweden, 2003-2015

Exhibit 5-37:  Market for Glucose Meters, Sweden, 2003-2015

Exhibit 5-38:  Market for Insulin Pumps, Sweden, 2003-2015

Exhibit 5-39:  Market for Insulin and Other Diabetes Medications, United Kingdom, 2003-2015

Exhibit 5-40:  Market for Glucose Meters, United Kingdom, 2003-2015

Exhibit 5-41:  Market for Insulin Pumps, United Kingdom, 2003-2015

Exhibit 5-42:  Market for Insulin and Other Diabetes Medications, United States, 2003-2015

Exhibit 5-43:  Market for Glucose Meters, United States, 2003-2015

Exhibit 5-44:  Market for Insulin Pumps, United States, 2003-2015


Exhibit 6-1:  Abbott Laboratories Financial Data, 2004

Exhibit 6-2:  Bayer Group Financials, 2004

Exhibit 6-3:  Becton Dickinson Financials, 2004

Exhibit 6-4:  Bristol-Myers Squibb Financials, 2004

Exhibit 6-5:  Eli Lilly Financials, 2004

Exhibit 6-6:  Glaxo SmithKline Financials, 2004

Exhibit 6-7:  Glaxo SmithKline Diabetes Products in Research Pipeline

Exhibit 6-8:  J&J Medical Devices and Diagnostics Financials, 2004

Exhibit 6-9:  Medtronic Financials, 2004

Exhibit 6-10:  Merck KGaA Financials, 2004

Exhibit 6-11:  Novartis Financials, 2004

Exhibit 6-12:  Novo Nordisk Financials, 2004

Exhibit 6-13:  Pfizer leading products

Exhibit 6-14:  Pfizer Financials, 2004

Exhibit 6-15:  Roche Financials, 2004

Exhibit 6-16:  Sanofi Aventis, Leading Products 2004

Exhibit 6-17:  Sanofi-Aventis Financials, 2004

Exhibit 6-18:  Takeda Leading Products

Exhibit 6-19:  Takeda Financials, 2005


Report #D500 has been updated in the 2010 report #D510:  
"Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018"
Click for details



Report #D500: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2005-2015

Price:  $1,250 for print or PDF; $1,450 for both.


Order report online    .


MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.




Contact: Patrick Driscoll, (949) 891-1753.  (patrick AT mediligence DOT com)

Copyright © 2006 MedMarket Diligence, LLC. All rights reserved.
Revised: 02/16/11

Our clients

Or call
+1.949.415.2609 fax

advanced medical technologies blog

Medtech Startups

Medtech financing archives


Follow us on Twitter
Follow medmarket

MedMarket Diligence Reports Coverage


Medtech Startups
Online database of recent medtech startups



Contact Us